There's a warning for Brits ordering weight loss injections such as Mounjaro and Wegovy to take extra care as temperatures plummet.

The wellness industry is expected to be worth almost £6.7trillion by 2028 – so which trends should you jump aboard this year?

SOARING numbers of slimmers have had emergency hospital treatment for suspected fat jab side-effects, with three deaths ...

Warning as appetite-suppressing injections set to be approved in Britain in pill form which will lead to them becoming ...

Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...

Madrigal’s Rezdiffra tops $1B run-rate in MASH, but losses and rising GLP-1/FGF21 competition may cap upside into 2026. See ...

Whether it’s due to a desire to be healthier, a matter of necessity for one’s health, or simply the wish to look good, ...

GLP-1 weight loss drugs such as Ozempic and Wegovy have taken the world by storm. But some side effects, from the accepted - ...

Wegovy and Mounjaro are two popular weight loss injections available in the UK. Here’s how they differ, who they’re for and ...

The U.S. Food and Drug Administration has approved the first pill version of a GLP-1 drug for weight loss, a move that could significantly widen access to the treatment for ...

Until now, they've largely been injectable drugs - Ozempic, Wegovy, Mounjaro, Zepbound. They're all weekly shots. The Food and Drug Administration approved the Wegovy pill on December 22. It has the ...

For many, weight-loss drugs like Ozempic, Wegovy, and Mounjaro have offered a new option and, for some, a necessary one.